Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Laser Treatment for the Improvement of Scars and Scleroderma

NCT: NCT04567537 · TERMINATED

NCT IDNCT04567537
StatusTERMINATED
Start Date2021-06-02
Completion2025-04-10

Brief Summary

In this study, the investigators seek to evaluate the effects of a laser treatment on the redistribution/regeneration of collagen on the clinical, microscopic, and molecular profiles of hypertrophic scars and scleroderma.

Frequently Asked Questions

What is Laser Treatment for the Improvement of Scars and Scleroderma?

Laser Treatment for the Improvement of Scars and Scleroderma is a clinical trial registered under NCT04567537. Current status: TERMINATED.

What is the status of NCT04567537?

The current status of NCT04567537 (Laser Treatment for the Improvement of Scars and Scleroderma) is: TERMINATED.

When did Laser Treatment for the Improvement of Scars and Scleroderma start?

Laser Treatment for the Improvement of Scars and Scleroderma started on 2021-06-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑